4 days ago · TOKYO and BOSTON -- February 7, 2025 – Bain Capital, a leading global private investment firm, today announced it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation (“Tanabe Pharma”, “MTPC” or “the Company”) in a carve-out transaction from Mitsubishi Chemical Group Corporation. The investment is ...

3 days ago · Bain Capital, a leading global private investment firm, today announced it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corpo. Bain Capital, a leading global private ...

4 days ago · Following rumblings of a private equity bidding war late last year, Bain Capital has emerged triumphant on its quest to obtain Japanese drugmaker Mitsubishi Tanabe Pharma. Bain is laying out 510 ...

4 days ago · US private equity firm Bain Capital has agreed to acquire Mitsubishi Chemical Group’s pharmaceutical unit Mitsubishi Tanabe Pharma in a deal valued at approximately Y510bn ($3.3bn).

4 days ago · Bain buys 340-year-old pharma company to fast-track Japan’s drug development Private equity firm expects $3.3bn acquisition of Tanabe will get boost from eased approval process for new medicine

4 days ago · U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), saying it was encouraged by prospects of regulatory change for Japan's ...

3 days ago · Private equity firm Bain Capital agreed to acquire Mitsubishi Chemical Group Corp.’s pharmaceutical unit, adding to a dealmaking boom in Japan.. The deal values Mitsubishi Tanabe Pharma Corp. at ...

14 hours ago · Bain Capital, a global private investment firm, has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation (MTPC) from Mitsubishi Chemical Group Corporation.The investment values the business at approximately $3.3 billion. Through the discovery and development of innovative drugs that address unmet medical needs, MTPC focuses on several priority therapeutic areas ...

4 days ago · TOKYO & BOSTON--(BUSINESS WIRE)--Bain Capital, a leading global private investment firm, today announced it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation (“Tanabe Pharma”, “MTPC” or “the Company”) in a carve-out transaction from Mitsubishi Chemical Group Corporation. The investment is being led by ...

3 days ago · US investment group Bain Capital has agreed to buy Mitsubishi Tanabe Pharma for JPY 510 billion (around $3.4 billion), setting up one of the largest private equity buyouts in Japan's healthcare ...